BioXcel Therapeutics, Inc. Stock Issued During Period, Shares, New Issues
BioXcel Therapeutics, Inc. (BTAI) had Stock Issued During Period, Shares, New Issues of 188.00 thousand shares as of 2025-03-03, per its 10-Q filed 2025-08-12.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2025-08-12
- 2025-03-03: Stock Issued During Period, Shares, New Issues 188.00K shares.
- 2021-06-30: Stock Issued During Period, Shares, New Issues 1 month 3.15M shares.
- 2020-07-31: Stock Issued During Period, Shares, New Issues 1 month 4.00M shares.
- 2020-02-29: Stock Issued During Period, Shares, New Issues 1 month 2.30M shares.
| Period end | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 1 month | Stock Issued During Period, Shares, New Issues 2 month |
|---|---|---|---|
| 2025-03-03 | 188.00K shares 10-Q · filed 2025-08-12 | ||
| 2021-06-30 | 3.15M shares 10-K · filed 2023-03-16 | ||
| 2020-07-31 | 4.00M shares 10-K · filed 2022-03-11 | ||
| 2020-02-29 | 2.30M shares 10-K · filed 2022-03-11 | ||
| 2019-09-30 | 2.30M shares 10-K · filed 2021-03-12 | ||
| 2019-09-26 | 2.30M shares 10-Q · filed 2020-11-12 | ||
| 2018-02-28 | 283.45K shares 10-Q · filed 2018-11-09 | 283.45K shares 10-K · filed 2020-03-09 | |
| 2018-01-31 | 283.45K shares 10-Q · filed 2018-11-09 | ||
| 2017-10-31 | 271.84K shares 10-K · filed 2019-03-12 | ||
| 2017-09-30 | 155.71K shares 10-K · filed 2019-03-12 | ||
| 2017-02-28 | 283.45K shares 10-Q · filed 2018-08-08 | ||
| 2017-01-31 | 283.45K shares 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |